References
Ocak ÖK, Ergenc H, Ergenc Z, Gökosmanoğlu F (2022) The localization of thyroid cancers on the thyroid gland is a new risk factor for metastases of perithyroidal, peritracheal and central lymph nodes. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-022-07361-3
Campennì A, Giovanella L, Siracusa M, Stipo ME, Alibrandi A, Cucinotta M, Ruggeri RM, Baldari S (2014) Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? Thyroid 24(11):1607–1611. https://doi.org/10.1089/thy.2014.0217
Campennì A, Ruggeri RM, Siracusa M, Giacoppo G, La Torre F, Saccomanno A, Alibrandi A, Dionigi G, Tuccari G, Baldari S, Giovanella L (2021) Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer. Eur J Endocrinol 185(3):397–404. https://doi.org/10.1530/EJE-21-0328
Campennì A, Barbaro D, Guzzo M, Capoccetti F, Giovanella L (2020) Personalized management of differentiated thyroid cancer in real life—practical guidance from a multidisciplinary panel of experts. Endocrine 70(2):280–291. https://doi.org/10.1007/s12020-020-02418-x
Campennì A, Piantanida R, Giovanella L (2020) Is isthmic enucleo-resection a reliable treatment for isthmic differentiated thyroid carcinoma? A note of caution. J Endocrinol Invest 43(12):1829–1830. https://doi.org/10.1007/s40618-020-01289-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they do not have any financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Campennì, A., Siracusa, M., Ruggeri, R.M. et al. Malignant thyroid nodule topography as additional risk factor for lymph-node metastases in differentiated thyroid cancer patients. Eur Arch Otorhinolaryngol 279, 5969–5970 (2022). https://doi.org/10.1007/s00405-022-07411-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07411-w